UA41376C2 - PHARMACEUTICAL COMPOSITION FOR TREATING ANDROGENIC ALOPECIA USING INHIBITOR OF 5<font face="Symbol">a</font>-REDUCTASE - Google Patents

PHARMACEUTICAL COMPOSITION FOR TREATING ANDROGENIC ALOPECIA USING INHIBITOR OF 5<font face="Symbol">a</font>-REDUCTASE

Info

Publication number
UA41376C2
UA41376C2 UA96041480A UA96041480A UA41376C2 UA 41376 C2 UA41376 C2 UA 41376C2 UA 96041480 A UA96041480 A UA 96041480A UA 96041480 A UA96041480 A UA 96041480A UA 41376 C2 UA41376 C2 UA 41376C2
Authority
UA
Ukraine
Prior art keywords
font
reductase
inhibitor
pharmaceutical composition
symbol
Prior art date
Application number
UA96041480A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Гленн Дж. Гомлі
Гленн Дж. Гомли
Кейт Д. Кауфман
Елізабет Стонер
Элизабет Стонер
Джоан Вальдштрайхер
Original Assignee
Мерк Енд Ко., Інк.
Мерк Энд Ко., Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Енд Ко., Інк., Мерк Энд Ко., Инк. filed Critical Мерк Енд Ко., Інк.
Priority claimed from PCT/US1994/011507 external-priority patent/WO1995010284A1/en
Publication of UA41376C2 publication Critical patent/UA41376C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to the treatment of androgenic alopecia. The oral pharmaceutical composition for treating androgenic alopecia comprises the inhibitor of 55-reductase at a dose of 0.05-3.0 mg.
UA96041480A 1993-10-15 1994-10-11 PHARMACEUTICAL COMPOSITION FOR TREATING ANDROGENIC ALOPECIA USING INHIBITOR OF 5<font face="Symbol">a</font>-REDUCTASE UA41376C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13852093A 1993-10-15 1993-10-15
US20490594A 1994-03-17 1994-03-17
PCT/US1994/011507 WO1995010284A1 (en) 1993-10-15 1994-10-11 Method of treating androgenic alopecia with 5-alpha reductase inhibitors

Publications (1)

Publication Number Publication Date
UA41376C2 true UA41376C2 (en) 2001-09-17

Family

ID=74219119

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96041480A UA41376C2 (en) 1993-10-15 1994-10-11 PHARMACEUTICAL COMPOSITION FOR TREATING ANDROGENIC ALOPECIA USING INHIBITOR OF 5<font face="Symbol">a</font>-REDUCTASE

Country Status (1)

Country Link
UA (1) UA41376C2 (en)

Similar Documents

Publication Publication Date Title
TW350844B (en) Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases
HK1022437A1 (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer&#39;s disease
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
YU49026B (en) THE USE OF 17 ß -(N-TERT-BUTYLCARBAMOYIL)-4-AZA-5-ALPHA-ANDROST-1-ENE-3-ONE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ANDROGENIC ALOPECIA
UA41355C2 (en) Agent for treating neuro-aids
ZA953537B (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
GEP20032943B (en) Oral Composition of Levosimendan
NZ320355A (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6- tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
HUT73529A (en) New bis-naphthalimides for the treatment of cancer
ZA941464B (en) Use of pregnane derivative
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
NZ326345A (en) Composition containing diosgenin
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
MX9702253A (en) Novel estrenes for inducing hypothalamic effects.
UA41376C2 (en) PHARMACEUTICAL COMPOSITION FOR TREATING ANDROGENIC ALOPECIA USING INHIBITOR OF 5&lt;font face=&#34;Symbol&#34;&gt;a&lt;/font&gt;-REDUCTASE
EP0743068A3 (en) Composition for inhibiting bone loss containing vanadyl sulfate
ES2065855A1 (en) Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
IL112110A0 (en) Octahydro-1h-isoindoles and pharmaceutical compositions containing them
UA29461C2 (en) An agent for treatment of amyloidosis, a method for treatment of amyloidosis
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
PL318539A1 (en) Inhibition of biosynthesis
IL108155A0 (en) Pharmaceutical compositions containing 17 alphadihydroequilenin or an ester or salt thereof
UA28288A (en) Method for treatment of schizophrenia
EP0870510A3 (en) Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents